NCT05547321
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05547321
Title Efficacy and Safety Study of OMTX705, Monotherapy and Anti-PD-1-combined, in Subjects With Advanced Solid Tumors.
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Oncomatryx Biopharma S.L.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ESP

Facility Status City State Zip Country Details
Beth Israel Deaconess Medical Center RECRUITING Boston Massachusetts 02215 United States Details
Hospital Universitari Vall d'Hebron NOT_YET_RECRUITING Barcelona Barcelona Spain Details
ICO L'Hospitalet RECRUITING L'Hospitalet de Llobregat Barcelona Spain Details
Hospital Clínico Universitario de Santiago NOT_YET_RECRUITING Santiago de Compostela Galicia 15706 Spain Details
Hospital Universitario de Donostia RECRUITING San Sebastián Guipúzcoa Spain Details
Hospital 12 Octubre RECRUITING Madrid Madrid Spain Details
Hospital MD Anderson RECRUITING Madrid Madrid Spain Details
Clínica Universitaria de Navarra RECRUITING Pamplona Navarre Spain Details
Onkologikoa RECRUITING San Sebastián Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field